Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Price to Sales (2012 - 2026)

Updated

Vistagen Therapeutics' (VTGN) Price to Sales came in at 6.01 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 96.9% from 194.46 a year earlier but up 47.3% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Price to Sales (2012 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics' Price to Sales stood at 18.43, down 87.7% from FY2025.

  • In prior fiscal years, Vistagen Therapeutics' Price to Sales was 149.99 in FY2025 (+56.2%), 96.04 in FY2024 (-23.1%), 124.85 in FY2023 (-46.0%) and 231.10 in FY2022 (+37.2%).
  • Quarterly Price to Sales has run from a low of 4.08 in fiscal Q1 2027 to a high of 266.48 in fiscal Q3 2022 over five years.
  • On a year-over-year basis, Price to Sales has declined in each of the last four quarters, with an average decline of 25.5% over the last eight quarters.
  • The strongest year-over-year quarter for Price to Sales in the past five years was fiscal Q1 2025, with growth of 931.2%; the weakest was fiscal Q2 2027, with a decline of 96.9%.
  • According to Business Quant data, Price to Sales for the three prior fiscal quarters was 4.08 (Q1 2027), 18.42 (Q4 2026) and 33.10 (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn
9 Gsk 193.54 Bn 176.38 Bn -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 6.01
Jun 30, 2026 4.08
Mar 31, 2026 18.42
Dec 31, 2025 33.10
Sep 30, 2025 194.46
Jun 30, 2025 94.99
Mar 31, 2025 149.99
Dec 31, 2024 128.03
Sep 30, 2024 99.54
Jun 30, 2024 98.18
Mar 31, 2024 95.06
Dec 31, 2023 127.79
Sep 30, 2023 61.48
Jun 30, 2023 9.52
Mar 31, 2023 18.18
Dec 31, 2022 14.56
Sep 30, 2022 19.40
Jun 30, 2022 170.91
Mar 31, 2022 231.10
Dec 31, 2021 260.94
API Access

Vistagen Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=VTGN&period=max&api_key=YOUR_API_KEY